References

Abington Police Department. 1995. "Prescription Enforcement Program." Submission for the Herman Goldstein Award for Excellence in Problem-Oriented Policing.

Alvarez, Lizette. 2011. "Florida Shutting 'Pill Mill' Clinics." New York Times, August 31, A1.

Amari, Erica, Jurgen Rehm, Elliot Goldner, and Benedikt Fischer. 2011. "Nonmedical Prescription Opioid Use and Mental Health and Pain Comorbidities: A Narrative Review." Canadian Journal of Psychiatry 56(8): 495–502.

Baehren, David, Catherine Marco, Danna Droz, Sameer Sinha, E. Megan Callan, and Peter Akpunonu. 2010. "A Statewide Prescription Monitoring Program Affects Emergency Department Prescribing Behaviors." Annals of Emergency Medicine 56(1): 19-23.e1–3.

Barthwell, Andrea, Michael Barnes, Vera Leopold, and Jana Wichelecki. 2011. "A Vital Balancing Act: Multi-Sector Approaches to Preventing Prescription Drug Abuse in the United States while Ensuring Adequate Patient Access to Medications." The Journal of Global Drug Policy and Practice 3(1): 1–11.

Basca, Belinda. 2008a. "The Elderly and Prescription Drug Misuse and Abuse." Prevention Tactics 9(2): 1–7.

------ 2008b. "Youth Prescription Drug Abuse: A Growing Concern." Prevention Tactics 9(1): 1–8.

Blumenschein, Karen, Joseph Fink III, Patricia Freeman, Kenneth Kirsh, Douglas Steinke, and Jeffery Talbert. 2010. Independent Evaluation of the Impact of the Effectiveness of the Kentucky All Schedule Prescription Electronic Reporting Program (KASPER). Lexington, Kentucky: Institute for Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Kentucky.

California State Task Force on Prescription Drug Misuse. 2009. Summary Report and Recommendations on Prescription Drugs: Misuse, Abuse and Dependency. Sacramento: California Department of Alcohol and Drug Programs.

Centers for Disease Control and Prevention. 2011. "Vital Signs: Opioid Prescription Pain Relievers – United States – 1999-2008." Morbidity and Mortality Weekly Report 60(43): 1487–1492.

Chen, Lucy, Mary Houghton, Lindsey Seefeld, Charlene Malarick, and Jianren Mao. 2011 "Opioid Therapy for Chronic Pain: Physicians' Attitude and Current Practice Patterns." Journal of Opioid Management 7(4): 267–76.

Eadie, John, and Scott Serich. 2007. PMP Committee Phase II PMIX Pilot Project Survey of State Prescription Monitoring Programs. Washington, D.C.: U.S. Department of Justice, Office of Justice Programs, Bureau of Justice Assistance.

Elhwairis, Huda, and Christopher B. Reznich. 2010. "An Educational Strategy for Treating Chronic, Noncancer Pain with Opioids: A Pilot Test." Journal of Pain 11(12): 1368–1375.

Elliott, Eric, Christopher Souder, Troy Privette, and William Richardson (2008). "Teen Prescription Drug Abuse: A National Epidemic." Clinician Reviews 18(11): 18–23.

Executive Office of the President of the United States. 2011. Epidemic: Responding to America's Prescription

Drug Abuse Crisis. Washington, D.C.: Executive Office of the President of the United States, Office of National Drug Control Policy.

Fass, Jennifer. 2011. "Prescription Drug Take Back Programs." American Journal of Health-System Pharmacy 68(7): 567–570.

Feldman, Lance, Kristi Williams, John Coates, and Michele Knox. 2011. "Awareness and Utilization of a Prescription Monitoring Program Among Physicians." Journal of Pain & Palliative Care Pharmacotherapy 25(4): 313–317.

Fishman, Scott. 2004. "Repeal of Triplicate Prescribing and the New Security Paper Prescription Requirement in California." CSA Bulletin (January-March): 46–52.

Florida Department of Law Enforcement, Office of Statewide Intelligence. 2001.Overview of Prescription Drug Abuse and the Oxycodone Problem in Florida. Tallahassee, Florida: Florida Department of Law Enforcement.

Forgione, Dana A., P. Neuenschwander, and T. Vermeer. 2001. "Diversion of Prescription Drugs to the Black Market: What the States Are Doing to Curb the Tide."Journal of Health Care Finance 27(4): 65–78.

Forman, Robert. 2006. "Narcotics on the Net: The Availability of Web Sites Selling Controlled Substances." Psychiatric Services 57(1): 24–26.

Fountain, Jane, Paul Griffiths, Michael Farrell, Michael Gossop, and John Strang. 1997. "Diversion Tactics: How a Sample of Drug Misusers in Treatment Obtained Surplus Drugs to Sell on the Illicit Market." International Journal of Drug Policy 9(3): 159–167.

Garnier, Laura, Amelia Arria, Kimberly Caldeira, Kathryn Vincent, Kevin O'Grady, and Eric Wish. 2010. "Sharing and Selling of Prescription Medications in a College Student Sample." Journal of Clinical Psychiatry 71(3): 262–269.

Health Canada. 2005. Abuse and Diversion of Controlled Substances: A Guide for Health Professionals. Ottawa: Health Canada.

Inciardi, James and Hilary Surratt. 2005. Research Issues and Experiences in Studying Prescription Drug Diversion. Bethesda, Maryland: College on Problems of Drug Dependence Conference on the Impact of Drug Formulation on Abuse Liability, Safety and Regulatory Decisions.

Inciardi, James, Hilary Surratt, Steven Kurtz, and John Burke. 2006. "The Diversion of Prescription Drugs by Health Care Workers in Cincinnati, Ohio." Substance Use & Misuse 41(2): 255–264.

Inciardi, James, Hilary Surratt, Steven Kurtz, and Theodore Cicero. 2007. "Mechanisms of Prescription Drug Diversion Among Drug-Involved Club- and Street-Based Populations." Pain Medicine 8(2): 171–183.

Inciardi, James, Hilary Surratt, Theodore Cicero, Andrew Rosenblum, Candice Ahway, J. Elise Bailey, Richard Dart, and John Burke. 2010. "Prescription Drugs Purchased Through the Internet: Who Are the End Users?" Drug & Alcohol Dependence 110(1-2): 21–29.

Johnson, Erin, Christina Porucznik, Jonathan Anderson, and Robert Rolfs. 2011. "State-Level Strategies for Reducing Prescription Drug Overdose Deaths: Utah's Prescription Safety Program." Pain Medicine 12:S66–72.

Joranson, David E., Grant M. Carrow, Karen M. Ryan, Linda Schaefer, Aaron M. Gilson, Patricia Good, John Eadie, Susan Peine, and June L. Dahl. 2002. "Pain Management and Prescription Monitoring."Journal of Pain and Symptom Management 23(3): 231–238.

Katz, Nathaniel, Lee Panas, M. Kim, Adele Audet, Arnold Bilansky, John Eadie, Peter Kreiner, Florence Paillard, Cindy Thomas, and Grant Carrow. 2009. "Usefulness of Prescription Monitoring Programs for Surveillance – Analysis of Schedule II Opioid Prescription Data in Massachusetts, 1996-2006." Pharmacoepidemiology and Drug Safety 19(2): 115–123.

Kentucky Cabinet for Health and Family Services and Kentucky Injury Prevention and Research Center. 2010. 2010 KASPER Satisfaction Survey: Executive Summary. Frankfort, Kentucky: Kentucky Cabinet for Health and Family Services; Lexington, Kentucky: Kentucky Injury Prevention and Research Center.

LaBelle, Regina, Mac Venzon, and Emanuel Barthe. 2011. Addressing the Problem of Prescription Fraud. Miami: Presentation at the 22nd Annual Problem-Oriented Policing Conference.

Lambert, David. 2007. Impact Evaluation of Maine's Prescription Drug Monitoring Program: Executive Summary. Portland, Maine: Muskie School of Public Service, University of Southern Maine.

Lineberry, Timothy, and Michael Bostwick. 2004. "Taking the Physician Out of Physician Shopping': A Case Series of Clinical Problems Associated With Internet Purchases of Medication." Mayo Clinic Proceedings 79(8): 1031–1034.

Manchikanti, Laxmaiah, Bert Fellows, Harry Ailinani, and Vidyasagar Pampati. 2010. "Therapeutic Use, Abuse, and Nonmedical Use of Opioids: A Ten-Year Perspective." Pain Physician 13(5): 401–435.

Massachusetts OxyContin and Other Drug Abuse Commission. 2006. Final Report. Boston: Massachusetts Senate and House of Representatives Joint Committee on Public Health.

Maxwell, Jane. 2006. Trends in the Abuse of Prescription Drugs. Austin, Texas: Gulf Coast Addiction Technology Transfer Center, University of Texas at Austin.

McCabe, Sean, John Knight, Christian Teter, and Henry Wechsler. 2005. "Non-Medical Use of Prescription Stimulants Among U.S. College Students: Prevalence and Correlates from a National Survey." Addiction 99(1): 96–106.

McCabe, Sean, Christian Teter, Carol Boyd, John Knight, and Henry Wechsler. 2005. "Nonmedical Use of Prescription Opioids Among U.S. College Students: Prevalence and Correlates from a National Survey." Addictive Behaviors 30(4): 789–805.

Middleton, H. 2000. "Electronically Transmitted Prescriptions – A Good Idea?"The Pharmaceutical Journal 265(7107): 172–176.

National Alliance for Model State Drug Laws. 2010. State Doctor Shopping & Prescription Fraud Statutes. Santa Fe, New Mexico: The Alliance.

National Association of State Controlled Substances Authorities and Alliance of States With Prescription Monitoring Programs 2002.Prescription Monitoring Program Model Act.

National Center on Addiction and Substance Abuse at Columbia University. 2005. Under the Counter: The Diversion and Abuse of Controlled Prescription Drugs in the U.S. New York: CASA.

National Institute on Drug Abuse. 2010. "Prescription Drug Abuse." Topics in Brief – A Research Update from the National Institute on Drug Abuse. December.

------ 2007. Monitoring the Future National Results on Adolescent Drug Use: Overview of Key Findings, 2006.

New York State Department of Health. 2010. "State Prescription Forms Reducing Fraud and Abuse." www.health.ny.gov/press/releases/2007/2007-07-31_prescription_fraud_savi....

Ohio Prescription Drug Abuse Task Force. 2010. Final Report: Task Force Recommendations. Columbus, Ohio: The Task Force.

Partnership for a Drug-Free America. 2006. The Partnership Attitude Tracking Study (PATS). New York: Partnership for a Drug-Free America.

Payne, Brian, and Dean Dabney. 1997. "Prescription Fraud: Characteristics, Consequences, and Influences." Journal of Drug Issues 27(4): 807–820.

PMP Center of Excellence, Brandeis University. 2011. "Staying Clear of the Law and Addiction: Nevada's Pre-Criminal Intervention Program." Notes from the Field. Waltham, Massachusetts: PMP Center of Excellence, Brandeis University.

Ramer, P. 2001. Overview of Prescription Drug Abuse and the Oxycodone Problem in Florida.Tallahassee, Florida: Florida Department of Law Enforcement, Office of Statewide Intelligence.

Reifler, Liza, Danna Droz, J. Elise Bailey, Sidney Schnoll, Reginald Fant, Richard Dart, and Becki Bartelson. 2012. "Do Prescription Monitoring Programs Impact State Trends in Opioid Abuse/Misuse?" Pain Medicine 13(3): 434–442.

Reisman, Richard, Pareen Shenoy, Adam Atherly, and Christopher Flowers. 2009. "Prescription Opioid Usage and Abuse Relationships: An Evaluation of State Prescription Drug Monitoring Program Efficacy." Substance Abuse: Research and Treatment 3(1): 41–51.

Rigg, Khary, Samantha March, and James Inciardi. 2010. "Prescription Drug Abuse & Diversion: Role of the Pain Clinic." Journal of Drug Issues 40(3): 681–702.

Rossman, Shelli, John Roman, Janine Zweig, Michael Rempel, and Christine Lindquist. 2011. The Multi-Site Adult Drug Court Evaluation: Executive Summary. Washington, D.C.: Urban Institute.

Substance Abuse and Mental Health Services Administration. 2011a. Results from the 2010 National Survey on Drug Use and Health: Summary of National Findings, NSDUH Series H-41, HHS Publication No. (SMA) 11-4658. Rockville, Maryland: SAMHSA. Available at www.samhsa.gov/data/NSDUH/2k10NSDUH/2k10Results.htm.

------ 2011b. The NSDUH Report: Illicit Drug Use among Older Adults. Rockville, Maryland: SAMHSA, Center for Behavioral Health Statistics and Quality.

------ 2008. "Nonmedical Stimulant Use, Other Drug Use, Delinquent Behaviors, and Depression among Adolescents." The NSDUH Report. Washington, D.C.: SAMHSA, Office of Applied Studies.

Teter, Christian, Sean McCabe, Kristy LaGrange, Jason Cranford, and Carol Boyd. 2006. "Illicit Use of Specific Prescription Stimulants among College Students: Prevalence, Motives, and Routes of Administration." Pharmacotherapy 26(10): 1501–1510.

U.K. Department of Health. 2008. "Security of Prescription Forms." National Health Service Circular. www.nhsbsa.nhs.uk/PrescriptionServices/Documents/security_prescriptions.pdf.

U.S. Drug Enforcement Administration, Office of Diversion Control. 2011a. Questions and Answers: State Prescription Drug Monitoring Programs. Washington, D.C.: U.S. Drug Enforcement Administration. www.deadiversion.usdoj.gov/faq/rx_monitor.htm.

------ 2011b. National Prescription Drug Threat Assessment, 2010. Johnstown, Pennsylvania: U.S. Drug Enforcement Administration, National Drug Intelligence Center.

------ 2000. "A Pharmacist's Guide to Prescription Fraud." Informational Brochures 1(1).

U.S. General Accounting Office. 2003. Prescription Drugs: OxyContin Abuse and Diversion and Efforts to Address the Problem. Washington, D.C.: U.S. General Accounting Office.

Wang, Jing, and Paul Christo. 2009. "The Influence of Prescription Monitoring Programs on Chronic Pain Management." Pain Physician 12(3): 507–515.

Weiss, Roger, Jennifer Potter, David Fiellin, Marilyn Byrne, Hilary Connery, William Dickinson, John Gardin, et al. 2011. "Adjunctive Counseling During Brief and Extended Buprenorphine-Naloxone Treatment for Prescription Opioid Dependence: A 2-phase Randomized Controlled Trial." Archives of General Psychiatry 68(12): 1238–1246.

Wick, J. 1995. "Outsmarting Prescription Fraud."Pharmacy Times 61(33): 35–36.

Wilford, Bonnie. 1990. "Abuse of Prescription Drugs."Addiction Medicine 152:609–612.

Wu, Li-Tzy, Daniel Pilowsky, and Ashwin Patkar. 2008. "Non-Prescribed Use of Pain Relievers Among Adolescents in the United States." Drug and Alcohol Dependence 94(1-3): 1–11.

Young, April, and Jennifer Havens. 2012, "Transition from First Illicit Drug Use to First Injection Drug Use Among Rural Appalachian Drug Users: A Cross-Sectional Comparison and Retrospective Survival Analysis." Addiction 107(3): 587–596.